Telomerase activity in chronic inflammatory bowel disease

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Ulcerative colitis (UC) patients face a higher risk of colorectal cancer (CRC).
• Telomerase, linked to cellular immortality, is a potential marker in cancer development (carcinogenesis).

Purpose of the Study:

• To investigate telomerase activity as a diagnostic and prognostic marker in colorectal carcinogenesis.
• To assess telomerase levels in normal, adjacent, and tumor tissues of colon adenocarcinoma.
• To evaluate telomerase activity in ulcerative colitis and Crohn's disease patients compared to controls.

Main Methods:

• Telomerase activity was measured using a 0-4 scoring system in surgical specimens and colon biopsies.
• Compared telomerase scores in normal, tumor-adjacent, and tumor-center tissues from seven colon adenocarcinoma patients.
• Assessed telomerase activity in colon biopsies from patients with ulcerative colitis, Crohn's disease, and controls.

Main Results:

• Colon adenocarcinoma showed significantly increased telomerase activity from normal to tumor tissues (0.7 to 3.0).
• Telomerase activity was low and comparable across ulcerative colitis (0.4-1.0), Crohn's disease (0.3-0.6), and control groups (0.4).
• Low telomerase activity was observed in the colonic mucosa of all patient groups, irrespective of disease duration or severity.

Conclusions:

• Telomerase is upregulated in established colon adenocarcinoma but not in the premalignant state of active ulcerative colitis.
• Telomerase does not appear to have prognostic value as an early tumor marker for colorectal cancer in ulcerative colitis patients.
• Further investigation is required to elucidate the role of telomerase in early inflammatory bowel disease-associated carcinogenesis.